Market Flash

In a recent showcase at Expodireto 2024, Agrocete, a multinational company based in Brazil, presented its innovative bioinoculant called NOD PHOS, which promotes nitrogen fixation, plant growth, and phosphorus solubilization.

Bayer Crop Science has made a significant move by applying for the deregulation of five herbicides, including glyphosate and mesotrione, for corn variety MON 87429 in the United States.

In a distressing turn of events, a red yeast rice supplement produced by Kobayashi Pharmaceutical has been associated with two deaths and the hospitalization of 106 individuals, according to recent reports.

Singapore-based skincare brand Allies of Skin has raised $20 million from Meaningful Partners.

• Allies of Skin
• Meaningful Partners

The skincare brand, founded by the Léa Nature group in 2011, has grown 38% over the past five years.

• Eau Thermale Jonzac

Arkema's range of advanced biomaterials, made from renewable castor seeds, have been independently analyzed and certified as being made from biochar and are now allowed to carry USDA BioPreferred Label.

• Arkema

In recent news, BRA Agroquímica has introduced a new herbicide called Derrete in Brazil, targeting weed control in sugarcane, pastures, and other crops.

In a recent development, Bryat Plant Oil Factory, the first fully integrated vegetable oil facility in Bryat Republic, opened in the outskirts of Ulan-Ude on March 22nd.

AbbieVie, a prominent player in the field of Antibody-Drug Conjugates (ADCs), has finally proven itself by successfully overcoming its challenges.

In a recent ranking by renowned global food website "Taste Atlas," Chilean Pisco has secured a place among the "Top 50 Spirits Worldwide."

In the realm of pharmaceutical innovation, a new wave of companies is emerging, demonstrating remarkable profitability and groundbreaking advancements.

In a stunning display of financial prowess, WuXi Biologics, a leading global contract research, development, and manufacturing organization (CRDMO) for biopharmaceuticals, has announced its exceptional performance in the year 2023.

This time, it is Japanese company Sosei Group Corporation that has announced the regaining of full ownership of HTL0027477 (formerly GSK4381406) from GlaxoSmithKline (GSK), marking GSK's official exit from the IBD field.

In a groundbreaking agreement, AriBio has announced the acquisition of exclusive marketing rights for AR1001, a potential treatment for early-stage Alzheimer's disease, in China.

BYK will build a new laboratory building at its Wesel site. BYK estimates the total project implementation period to be approximately four years and cost approximately €25 million. Completion is expected in the second quarter of 2028.

• BYK
• Wesel

The Germany-based specialty ingredients distributor has signed an exclusive agreement with Japanese cosmetic additives maker Taiyo.

• Grolman
• Taiyo

In a significant milestone for the pharmaceutical industry, Evive Biotech has achieved a major breakthrough with its innovative biopharmaceutical product, "Aibei Gesiting α Injection."

Hengrui Pharmaceuticals has recently unveiled the latest data from their innovative drug, Carrelizumab.

Stemirna Therapeutics, a leading biotechnology company, has announced the suspension of its groundbreaking mRNA personalized cancer vaccine, SW1115C3.

The United Kingdom has recently revised the maximum residue limits (MRLs) for certain pesticides in food products.